A federal judge yesterday ruled that Boston Scientific Corp. violated its agreements with an Israeli company when it set up a secret stent-making operation in Ireland in 1997, and he told the two companies to quickly reach a settlement or face a prompt trial he will hold to determine what damages, if any, Boston Scientific owes.